Free Trial vs Freemium Conversion Benchmarks in B2B SaaS

The 8% median that gets passed around in B2B SaaS conversion conversations is real, but it describes almost nothing. It comes from Kyle Poyar's January 2026 analysis of 200 B2B software products, built with ChartMogul and ProductLed, and it sits at the exact point where the distribution is thinnest. The shape of the data is bimodal: 20% of free trial products convert below 2.5%, another 23% convert above 25%, and hardly anyone clusters near the number everyone quotes. Per that same report, there's a 10x conversion difference between the top 20% of self-serve products and the bottom 20%. Benchmarking against 8% is benchmarking against a number almost no real product actually hits.

The practical damage this does is quiet but expensive. A team converting at 6% might be beating its segment badly, while a team at 15% could be underperforming its own category by a wide margin, and neither team would know it from the median alone. The number gives false comfort to the team that should be worried, and false alarm to the team that's actually doing fine. Before any benchmark is useful, a team has to identify its own reference class: which trial model, which vertical, which stage of the funnel is actually being measured.

How trial model choice reshapes the conversion number before a single user logs in

Three trial structures dominate the B2B SaaS market, and each one produces a fundamentally different conversion arithmetic before a single user has even logged in once.

Opt-in free trials, the kind that ask for an email but no credit card, are a widely used structure in the market. First Page Sage's 2025 dataset, covering 86 companies (71% B2B), puts organic trial-to-paid conversion at 18.2% and paid traffic at 17.4%. The 2026 ChartMogul study of 200 products puts opt-in conversion at 8.9%. Same model, wildly different numbers, because the two datasets weight company mix, traffic source, and vertical differently.

Opt-out trials, which require a credit card up front, show an even starker split: 48.8% in the 2025 data versus 31.4% in the 2026 ChartMogul figures. The two datasets differ in company mix, traffic source, and vertical weighting, which likely accounts for much of the gap. Freemium sits at the opposite extreme of the tradeoff. It produces the strongest visitor-to-signup numbers (13.3% organic, 15.9% paid) but converts only 2.6% of those free users into paying ones. Ungated freemium, which lets users experience the product before creating an account at all, lands somewhere between the trial and freemium numbers in the 2026 data.

The full-funnel comparison is where the model choice actually shows its teeth. Available benchmark data puts opt-out trials at 10.5 paying customers per 1,000 visitors, compared to 3.6 for opt-in trials. That's close to a 3x difference in net output from identical traffic, driven entirely by the friction added at signup.

Freemium's 2.6% free-to-paid rate looks alarming next to those trial numbers, until you remember what the model is actually built for. Dropbox built a business valued around $12 billion on a conversion rate in the neighborhood of 4%, because freemium's logic is reach, not per-signup efficiency. Slack tells a similar story from a different angle: roughly 80% of its paid workspaces started as free teams. Conversion rate was never the only measure of success in either case; it was one input into a much longer game about distribution.

This is also why two products can both claim "free trial conversion" and mean entirely different things. One is opt-in at 8.9%. The other is opt-out at 31.4%. Comparing those two figures directly tells a reader nothing, because the underlying friction at signup was never the same. And it's worth noting that 57% of the 200 products in the 2026 study use a free trial as their primary entry point, versus 26% for freemium and 7% for a reverse trial. Free trials dominate the market, which means most published benchmarks are quietly weighted toward that model, even when the report doesn't say so.

Why the same trial model produces vastly different rates across verticals and price points

Vertical isn't a footnote here, it's close to the whole story. CRM tools convert at a notably high trial-to-paid rate, per First Page Sage's 2025 data, the highest figure in the dataset. Cybersecurity comes in at a notably high rate, where the category tends to attract buyers with pressing needs. Enterprise software sits at a lower rate, one that reflects the structural complexity common in enterprise buying.

CRM and education cluster at 25% to 29%. Enterprise and fintech cluster at 18% to 19%. The gap between the top and bottom verticals is wider than the gap between a "good" and "great" performer inside a single vertical, which means most of the variance a team is chasing has already been decided by which category it competes in.

ACV band adds a second, parallel layer of segmentation. Enterprise SaaS products with an ACV above $10,000 convert at 12% to 18%, per ChartMogul's 2024 SaaS Benchmarks Report, a lower rate that nonetheless reflects a very different revenue profile per conversion. Meanwhile, products with ACVs above $50 a month see conversion rates 40% to 60% higher through trials compared to freemium, according to ProfitWell's 2025 SaaS Metrics Report. Price point changes not just the rate but which model even makes sense.

Enterprise products carry a specific structural problem worth naming directly: a severe visitor-to-trial bottleneck. Even when the backend conversion rate looks respectable, a low trial-start rate means very few paying customers emerge per 1,000 visitors. The bottleneck isn't in the trial experience at all, it's upstream of it.

Trial length interacts with all of this too. About 62% of products in the 2026 study run 14-day trials. Shorter trials create urgency, but they don't always fit the multi-week evaluation cycles common in complex B2B purchases, which makes trial length a lever a team can pull, not a fixed constant imposed by the market. Before consulting any benchmark, the real first question is narrower than "what's a good conversion rate." It's "what vertical, what ACV band, and what trial model am I actually in." Skip that step and the comparison is just noise.

The full-funnel view that single-metric conversion rates hide

A useful thought experiment makes the distortion obvious: send 1,000 visitors through each trial model and count what comes out the other end as paying customers.

Opt-in trials convert a smaller share of visitors into signups, but the per-signup conversion rate is strong enough to produce 3.6 paying customers per 1,000 visitors. Opt-out trials start from a lower signup rate too, since the credit card requirement filters out casual visitors, yet they still produce 10.5 paying customers per 1,000, nearly three times the opt-in output. Freemium wins the top of the funnel decisively, pulling in 13.3% of organic visitors as signups, but only 2.6% of those signups ever pay, so the net output per 1,000 visitors ends up modest despite the huge top-of-funnel number.

The upshot is that a freemium product can post a lower per-signup conversion rate than a no-card trial and still walk away with more paying customers from the same traffic, or the reverse, depending entirely on where in the funnel each model wins. Most teams measure signup-to-paid and stop there. Very few track visitor-to-paid as one continuous number, and that gap is exactly where a reported "15% conversion rate" can hide a top-of-funnel problem that's capping total revenue no matter how good the trial experience is downstream.

Denominator discipline matters just as much as funnel stage. Does the reported conversion rate count every signup, including ones who never logged in once? Does it include users on plans that were never eligible to convert, or bot signups that inflate the top of the funnel without ever being real prospects? Change the cohort definition and the reported rate moves, without a single thing about actual performance changing at all.

Once the funnel's real shape is visible, the next question isn't about the funnel anymore. It's about which specific behavior inside that funnel actually predicts conversion, and that's where activation takes over.

Activation as the variable that explains most of the spread within any segment

The average activation rate across SaaS and AI tools in 2025 sits at 37.5%. AI and ML products lead the pack at 54.8%, while fintech trails at just 5%, a range so wide within the same broad category that it dwarfs the gap between industry medians. Users who reach the activation moment, the point where they first genuinely experience the product's value, convert at meaningfully higher rates than users who don't, and that gap between activated and non-activated users explains most of the conversion spread inside any single segment.

Available benchmark data maps the activation decay curve across trial windows, and the shape of it should worry anyone relying on a 14-day trial. Users who are going to activate tend to do so early, and a large share of those who will ever engage are effectively lost in the first week alone.

That decay curve points to a practical conversion window that's much narrower than most trial lengths suggest. Most conversions happen right around when the trial expires, but the intervention window that actually matters is the first seven days, not the full trial length. After day 14, conversion rates fall to approximately 1%, at which point the trial is effectively over regardless of how many days remain on the clock.

Onboarding checklist completion, the metric most teams reach for as a proxy for activation, turns out to be a weak stand-in. Available benchmark data suggests checklist completion rates are low across B2B SaaS, with most signups abandoning the checklist before finishing. A checklist that most users abandon before finishing isn't moving the number anyone actually cares about.

Feature adoption tells a similarly sobering story. Average core feature adoption sits at just 24.5%, with a median of 16.5%, per benchmark data covering a broad sample of B2B SaaS companies. Most trial users never even reach the feature that would have triggered their decision to pay. How much of the product surface a user encounters early in the trial shapes whether they reach the moment that would have triggered a decision to pay.

So the question worth asking isn't "what's our conversion benchmark." It's what percentage of trial users are actually activating, and whether the team is reaching them inside that first seven-day window. That answer explains more variance than any industry figure ever will.

How product-qualified leads reframe what "conversion readiness" actually means

A product-qualified lead is a free user whose in-product behavior crosses a defined threshold of frequency, breadth of feature use, and depth of engagement. It has nothing to do with whether someone opened a marketing email or filled out a contact form.

Per ProductLed's 2025 PLG Benchmark report, free trials that use PQLs to guide their motion convert to paid at an average of 25%, a meaningfully higher rate than unqualified free accounts, representing a significant lift extracted from the exact same trial population just by paying attention to who's actually using the product. At higher ACV bands, that PQL-driven conversion climbs further, reaching a range where both self-serve and sales-assist motions are viable and the behavioral signal carries real weight in deciding which one to use.

High-performing PLG companies convert a substantially higher share of their PQLs into paying customers compared to marketing-qualified leads sourced the traditional way. The behavioral filter is doing qualification work that a form-fill simply can't replicate.

Yet the adoption gap here is wide. Only around 24% to 25% of PLG companies run a formal PQL framework at all, and activation gets tracked by just 34% of PLG companies despite being the primary signal available to them. Most teams are sitting on usage data that already tells them who's ready to buy, and routing leads by form-fill anyway.

The PQL definition itself isn't something to copy from a benchmark report. Frequency of use, breadth of feature adoption, and engagement depth above a threshold is the structure, but the actual threshold values have to come from a product's own cohort conversion and retention data, not from someone else's report. Routing logic matters just as much as identification does: a low-ACV account that crosses the PQL threshold belongs in a self-serve upgrade flow, while a higher-ACV account hitting that same signal warrants an actual sales touch. The behavioral signal is identical. What happens next isn't.

What teams consistently converting above the median actually measure and do differently

The top quartile of B2B SaaS trial products converts at 35% to 45%. The bottom 20% sit below 2.5%. That gap has almost nothing to do with product category and almost everything to do with how the trial experience is designed and how behavioral data actually gets acted on.

Three operational markers separate the two groups consistently. Activation rate above 70% functions as a ceiling for the best PLG companies, not a floor, against an industry average of 37.5%, which tells you how much room most teams still have. Time to first value gets measured in hours rather than days among top performers, against an industry average benchmark of 1 day and 12 hours, with the fastest-growing companies compressing that window substantially further. And conversion gets triggered by behavior, by a user actually reaching product value, rather than by a calendar simply running out on a 14-day countdown.

Guidance sent to trial users has to be grounded in two things at once: what the user has actually done in the product over time, and who they are, meaning their plan, their role, and their account configuration. A generic nudge blasted to an entire trial cohort is the onboarding equivalent of quoting the industry median: technically accurate, describing nobody in particular.

The specific move that separates high converters is identifying users who are working through the product in an inefficient way when a better path already exists, and then explaining how that better path actually fits their real workflow. That kind of contact accelerates activation, but it only works if the team knows both the user's current product state and their behavioral history well enough to make the message land as relevant rather than generic.

Just as important is knowing when to say nothing. Skipping a message when the evidence for it is weak matters as much as sending one when the evidence is strong. Frequency caps, quiet hours, and clear evidence thresholds keep guidance from turning into noise that users eventually learn to tune out entirely.

The metric that actually matters here is outcome, not output. Whether a user opened a message is a vanity number. Whether that user went on to successfully adopt the target behavior afterward is the number that connects to revenue, and teams converting above the median are measuring adoption across the eligible cohort and tracking repeated successful use, not counting opens and calling it a day.

One caveat belongs here, stated plainly: observed adoption after a piece of guidance went out is evidence, not proof. A user converting after receiving a nudge might have converted anyway. High-performing teams treat that distinction seriously and invest in cohort comparison to confirm an intervention actually moved the number, rather than simply correlating with users who were already headed toward yes.

Building your own reference class when no published benchmark fits your product

Before consulting any external benchmark, a team needs to answer four questions honestly about its own product, because skipping any one of them turns the comparison into noise.

Trial model comes first: opt-in, opt-out, freemium, ungated freemium, or reverse trial. Compare conversion only within the same model, since the friction added or removed at signup changes the entire arithmetic downstream. Vertical comes second, because CRM and education cluster at 25% to 29% conversion while enterprise and fintech cluster at 18% to 19%, and category alone sets a floor that no amount of onboarding polish will fully overcome. ACV band comes third: enterprise SaaS above $10,000 ACV benchmarks at 12% to 18%, and mid-market products behave according to an entirely different logic, one where PQL-driven routing between self-serve and sales-assist starts to matter more than raw trial mechanics. Traffic mix comes fourth, since organic and paid trial-to-paid rates diverge (organic trial-to-paid runs around 18.2% per the 2025 First Page Sage data), and blending the two sources together without separating them muddies whatever number comes out the other end.

A published benchmark that ignores all four of these dimensions was never describing a real product to begin with. It was describing an average of averages, smoothed until the shape that actually matters, the bimodal split between products converting below 2.5% and products converting above 25%, disappears entirely. The number that matters isn't the industry's median. It's the median of the handful of products that actually share a trial model, a vertical, and an ACV band with the one being measured, and building that reference class takes real work that no single report can do on a team's behalf.